Awards / Ratings
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| Fund Award 2012 €uro / €uro am Sonntag FCP OP Medical BioHealth-Trends EUR achieved second place in the biotech equity fund category over three years, Fundadvisor: Medical Strategy GmbH - February 2012 |
| Fund Award 2012 €uro / €uro am Sonntag FCP OP Medical BioHealth-Trends EUR H achieved third place in the biotech equity fund category over three years, Fundadvisor: Medical Strategy GmbH - February 2012 |
| STANDARD & POOR’S FUND MANAGEMENT RATING 2011-2012 For the eighth consecutive time Standard & Poor’s awarded the fund an AA rating after the latest review, and so Medical BioHealth-Trends is currently the highest rated fund in the biotech segment – as of: October 2011 |
| Sauren Golden Awards 2011 3 goldmedals for Dr. Michael Fischer excellent fund management in the category "Stocks Biotechnology", September 2011 |
| Fund Award 2011 €uro / €uro am Sonntag FCP OP Medical BioHealth-Trends EUR achieved first place in the biotech equity fund category over ten years, Fundadvisor: Medical Strategy GmbH - January 2011 |
| Fund Award 2011 €uro / €uro am Sonntag FCP OP Medical BioHealth-Trends EUR H achieved third place in the biotech equity fund category over five years, Fundadvisor: Medical Strategy GmbH - January 2011 |
| Fund Award 2011 €uro / €uro am Sonntag FCP OP Medical BioHealth-Trends EUR achieved second place in the biotech equity fund category over three years, Fundadvisor: Medical Strategy GmbH - January 2011 |
| STANDARD & POOR’S FUND MANAGEMENT RATING 2010-2011 For the seventh consecutive time Standard & Poor’s awarded the fund an AA rating after the latest review, and so Medical BioHe@lth-Trends is currently the highest rated fund in the biotech segment – as of: October 2010 |
| Sauren Golden Awards 2010 3 goldmedals for Dr. Michael Fischer excellent fund management in the category "Stocks Biotechnology", September 2010 |
| Fund Award 2010 €uro / €uro am Sonntag FCP OP Medical BioHe@lth-Trends EUR H achieved second place in the biotech equity fund category over three years, Fundadvisor: Medical Strategy GmbH - January 2010 |
| Fund Award 2010 €uro / €uro am Sonntag FCP OP Medical BioHe@lth-Trends EUR H achieved second place in the biotech equity fund category over one year, Fundadvisor: Medical Strategy GmbH - January 2010 |
| Fund Award 2010 €uro / €uro am Sonntag FCP OP Medical BioHe@lth-Trends achieved first place in the biotech equity fund category over one year, Fundadvisor: Medical Strategy GmbH - January 2010 |
| SAUREN FONDS RESEARCH AG Golden Award in the category "Sector Funds" |
| Sauren Golden Awards 2009 3 goldmedals for Dr. Michael Fischer excellent fund management in the category "Stocks Biotechnology" |
| Standard & Poor's Fund Management Rating AA AA Rating for the period 2009-2010 once again confirmed |
| Sauren Golden Awards 2008 For excellent fund management in the category "Stocks Biotechnology" |
| Standard & Poor's Fund Management Rating Certificate AA Rating for the period 2008-2009 once again confirmed |
| STANDARD & POOR'S FUND MANAGEMENT RATING AA detailed S & P Factsheet (as of September 08) |
| Lipper Fund Award Switzerland 2006 Best Fund over three years - Equity Sector Biotechnology |
| Sauren Golden Awards 2004 3 goldmedals for Dr. Michael Fischer excellent fund management in the category "Stocks Biotechnology" |
